SENSEX NIFTY

Api

Jul 28, 2014 at 20:46 | Source: PTI
In an open letter to PM, CII National Committee on Biotechnology Chairperson Kiran Mazumdar Shaw said the "unilateral fixing" of drug prices by NPPA based on "an inequitable formula" has done collateral damage to indigenous industry.
Jul 24, 2014 at 12:57 | Source: Moneycontrol.com
After inspecting the companys active pharmaceutical ingredients (APIs) manufacturing unit at Raltam, US Food and Drug Administration (US FDA) has raised some concerns in Form 483. Hence the drug manufacturer will suspend shipments to the US markets till the issue is addressed.
Jul 24, 2014 at 09:47 | Source: Moneycontrol.com
Ipca Laboratories has voluntarily decided to temporarily suspend API shipments from Ratlam manufacturing facility for the US markets till this issue addressed.
Jul 21, 2014 at 22:18 | Source: PTI
The US Food and Drug Administration (US FDA) has approved the sterile facility (plant-II) and solid dosage facility (plant -III) located at Verna in the adjoining coastal state, a company release said.
Jul 09, 2014 at 10:59 | Source: Moneycontrol.com
Ahmedabad-based pharmaceutical company Claris Lifesciences received approval from United States Food and Drug Administration (USFDA) for its finished dosage plant and API plant.
Jul 08, 2014 at 21:50 | Source: PTI
The company has three manufacturing plants at its campus on the outskirts of Ahmedabad. The company manufactures and markets products across various therapeutic segments including anesthesia, blood products, anti-infective and renal care.
Jul 07, 2014 at 13:19 | Source: Moneycontrol.com
The US-based injectable drugs major has completed acquisition of API manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals for around USD 218 million, it said.
Jun 27, 2014 at 11:06 | Source: CNBC-TV18
There are host of players which are already there with Diovan HCT, seven players are already there in the market with a combination, so upside for Ranbaxy will be limited, says Ranjit Kapadia of Centrum Broking
Jun 27, 2014 at 09:08 | Source: CNBC-TV18
After a long stretch of regulatory hassles, Vikas Dandekar of PharmAsiaNews.Com believes the worst is behind for the pharma major with this USFDA boost, a USD 3.4 billion opportunity.
Jun 20, 2014 at 15:54 | Source: CNBC-TV18
The Bangalore-based company has also raised the foreign institutional investor shareholding limit to 49 percent of paid up capital. The FII holding in the company is 0.15 percent as of March 31.
Messages on Api »

shmarketgen
ius

Platinum Member

369 Followers

Granules India  

How sustainable are the margins? Granules talks similar to Motherson...they both emphasize `efficiency` a lot.And rightfully so,an efficient usage of capacity & distribution network will enhance the revenues,without even demand rising up much! The China competition is receding in APIs

3.51 PM Jul 8th

Neha-Diwan

Platinum Member

819 Followers

Shasun Pharma  

Shasun Pharmaceuticals soars on completing USFDA inspection at API unit in Tamil Nadu.

1.28 PM Jul 8th

countryman

Platinum Member

411 Followers

Granules India  

Granules has five facilities as well as two additional facilities through its JVs • Granules’ Facilities (5) 1. Gagillapur – Finished Dosage and PFI 2. Bonthapally – Dedicated Paracetamol API Facility 3. Jeedimetla – Multi-Product API and PFI Facility 4. Bonthapally (Auctus) – Intermediate

12.50 PM Jul 8th

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th

Expert Chartist

Platinum Member

9622 Followers

Agio Paper  

At 10:49 hrs Agio Paper has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Jul 8th

venkatagopa
l

Platinum Member

372 Followers

Orchid Chemical  

drug API business and becoming smaller in size without reduction of equity. Promoters r at advantage at the cost of investors. But no problem to investors who entered since six months after THE crash! We have to see whether profit booking is taking place or new investment is coming! In quarter from

3.57 PM Jul 7th

Expert Chartist

Platinum Member

9622 Followers

Agio Paper  

At 10:59 hrs Agio Paper has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Jul 7th

Expert Chartist

Platinum Member

9622 Followers

Agio Paper  

At 10:42 hrs Agio Paper has formed a gap up chart pattern today. A Gap Up forms when the low for the day is higher than the previous days high. More technicals.

11.00 AM Jul 4th

sumkohli

New Member

0 Follower

Unitech  

Drama itna touchy ho rahe ho to jaa kar api securities agency khol lo and keep advising your client for all the longs and shorts.

3.30 PM Jul 3rd

MCX GURU BHAI

Platinum Member

1954 Followers

Commodities  

kareena ji the crude fall was due to bad ism manufacturing data not about api data and as per u if it`s sue to that could you tell me how and what sign shows that

11.54 PM Jul 1st

News across the web »
Aug 01, 2014 at 04:07 | Source: Economic Times
Jul 31, 2014 at 01:52 | Source: Calcutta Telegraph News
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.